CT scan revealednecrotic lymph nodes in the superior mediastinum and periportalregion, and multiple low attenuation lesions in the liver and spleen concerning for microabscesses from a disseminated infection.
[**2169-8-17**]: Induction chemotherapy with cytarabine and idarubicin complicated by persistent fevers and extensive workup ultimately revealing disseminated tuberculosis infection.
Liver Biopsy c/w GVHD.
Non-onc PMH - Disseminated TB - s/p treatment with INH, levofloxacin and rifabutin - Hypertension and a heart murmur - Diabetes mellitus type 2 - Chemo related heart failure and cardiomyopathy, EF 35-40% [**12-16**] - h/o atrial fibrillation, recent EKGs in NSR - CMV viremia ([**2-17**])  Social History: He is married and lives at home with his wife & children.
Physical Exam: PHYSICAL EXAMINATION ON TRANSFER TO BMT SERVICE: VS: T 98.7, BP 128/84, HR 86, RR 16, 96%RA GENERAL: Pleasant middle-aged man lying in bed in NAD HEENT: PERRL with anicteric sclerae.
LUNGS: Clear to auscultation bilaterally.
ABDOMEN: Soft, NT, ND, BS present, no HSM EXTREMITIES: 2+ pitting LE edema to knees bilaterally SKIN: Warm and dry with marked hyperpigmentation changes noted on his torso and lower extremity.
Pertinent Results: LABS ON ADMISSION: [**2171-12-4**] 10:40AM   WBC-2.2*# RBC-2.75* HGB-9.7* HCT-31.2* MCV-114* MCH-35.5* MCHC-31.2 RDW-22.4* [**2171-12-4**] 10:40AM   NEUTS-32* BANDS-0 LYMPHS-29 MONOS-35* EOS-0 BASOS-0 ATYPS-0 METAS-1* MYELOS-0 PROMYELO-3* NUC RBCS-14* [**2171-12-4**] 10:40AM   PLT SMR-VERY LOW PLT COUNT-27*# LPLT-2+ [**2171-12-4**] 10:40AM   GRAN CT-1150* [**2171-12-4**] 10:40AM   GLUCOSE-115* UREA N-41* CREAT-1.2 SODIUM-141 POTASSIUM-4.0 CHLORIDE-109* TOTAL CO2-23 ANION GAP-13 [**2171-12-4**] 10:40AM   ALT(SGPT)-231* AST(SGOT)-177* LD(LDH)-398* ALK PHOS-916* TOT BILI-1.3 DIR BILI-0.8* INDIR BIL-0.5 [**2171-12-4**] 10:40AM   ALBUMIN-3.3* CALCIUM-8.8 PHOSPHATE-2.1* MAGNESIUM-2.2 URIC ACID-6.0 .
STUDIES: * EKG [**12-5**]: Sinus tachycardia.
Compared to the previous tracing tachycardia has appeared.
* Echo [**12-9**]:  LV systolic function appears depressed.
There are no echocardiographic signs of tamponade.
* Echo [**12-6**]:  There is mild symmetric left ventricular hypertrophy with normal cavity size.
* Echo [**12-5**]: Very limited views.
* Echo [**12-4**]: Overall left ventricular systolic function is moderately depressed (LVEF= 30-40 %).
* CXR [**12-4**]: Marked short interval enlargement of the cardiac silhouette could  represent pericardial effusion or myocarditis.
There are no echocardiographic signs of tamponade.
# Pericardial effusion: In clinic he was found to have new cardiomegaly on CXR, and an echocardiogram revealed a large pericardial effusion.
Subsequent echocardiograms revealed no reaccumulation of the pericardial fluid.
The pericardial fluid studies were unrevealing.
He was sent home with an appointment for a repeat chest CT on [**2171-12-20**].
The marrow showed no sign of active leukemia.
His WBC was 2.2 on admission.
By discharge, however, his WBC was 5.5 with Hct 32 and platelets 63. .
DOCUSATE SODIUM 100 mg--1 capsule(s) by mouth twice a day Ergocalciferol (Vitamin D2) 50,000 unit--1 capsule(s) by mouth q  friday FOLIC ACID 1 mg--2 (two) tablet(s) by mouth once a day HUMALOG 100 unit/mL--per sliding scale Hydromorphone 2 mg--[**2-12**] tablet(s) by mouth every four (4) hours  as needed for pain Insulin Glargine 100 unit/mL--16 units sq daily METOPROLOL SUCCINATE 100 mg--1 tablet(s) by mouth daily NYSTATIN 100,000 unit/mL--5 ml by mouth four times a day swish and spit OMEPRAZOLE 20 mg--1 capsule(s) by mouth once a day OXYCONTIN 10 mg--3 (three) tablet(s) by mouth twice a day One Touch Test --as directed qac and qhs PREDNISOLONE ACETATE 1 %--1 drop ophthalmic twice a day PREDNISONE 20 mg--1 tablet(s) by mouth once a day PYRIDIUM 200 mg--0.5 (one half) tablet(s) by mouth once a day Posaconazole 200 mg/5 mL--1 suspension(s) by mouth three times a  day Pyridoxine 50 mg--2 tablet(s) by mouth once a day Saliva Substitution Combo No.2 --30 ml to mucous membrane q2 hours as needed for dryness TACROLIMUS 0.1 %--Apply to skin affected with gvhd.
Artificial Saliva 0.15-0.15 % Solution Sig: Thirty (30) ML Mucous membrane Q2H (every 2 hours) as needed.
Ergocalciferol (Vitamin D2) 50,000 unit Capsule Sig: One (1) Capsule PO QFRI (every Friday).
